Pharma Archive - Seite 2 von 2

11.05.2016

Mendoza FA et al. 2016; Severe eosinophilic fasciitis: Comparison of treatment with D-penicillamine plus corticosteroids versus corticosteroids alone; Scand. J. Rheumatol. 45(2):129-34

Study design: Long term prospective non-randomised trial to compare therapeutic effectiveness of corticosteroids (CS) and CS plus D-penicillamine (D-pen) in patients with … » Mehr

11.05.2016

Brancaleone V et al. 2016; D-penicillamine modulates hydrogen sulfide (H₂S) pathway through selective inhibition of cystathionine-gamma-lyase (CSE); Br. J. Pharmacol. 173(9):1556-65

Study design: D-penicillamine (D-pen) was tested on mouse artoa rings for its vasodilatory effect as a possible cysteine analogue and its effect on H2S … » Mehr

11.05.2016

Karakulak UN et al. 2015; An arrhythmic episode after mercury exposure and successful treatment with chelation therapy: A case report; Anatol. J. Cardiol. 15:586-91

Study design: This report surveys the case of a female patient presenting weakness of the limbs, malaise, fatigue, atypical chest pain and palpitation due to mercury … » Mehr

11.05.2016

Gaidukov SN et al. 2013; Features of the early neonatal period at children born from mothers with the critical values of mercury in their blood; Mod. Problems Sci. Educat. No. 6

Study design: This study compared several neonatal parameters of babies born by mothers with critical level of mercury in their blood who were either treated (group 1) with … » Mehr

04.05.2016

Mirzoev EB et al. 2015; The influence of hexacyanoferrate (II) potassium-ferric(III) as a radionuclide sorbent fed at different doses on clinical, hematological and physiological parameters in rats; Agric. Biol. 50(2):237-44

Study Design: Wistar rats received 0 mg/kg, 11.6 mg/kg, 23.2 mg/kg or 32.4 mg/kg hexacyanoferrate (II) potassium-ferric (III) orally for 30 days to compare influence on … » Mehr

29.04.2016

Parajuli D et al. 2013; Prussian blue nanoparticles for the enrichment of radioactive cesium in colutions; Waste Management Conference: International collaboration and continuous improvement, Phoenix, AZ (USA), 24-28 Feb 2013

Study Design: Prussian Blue (PB) nanoparticles in various forms were compared for their ability to adsorb cesium (Cs) from water. Results: Water dispersible nano-PB could … » Mehr

18.02.2015

Langlois DK et al. 2013; Pharmacokinetics and relative bioavailability of D-penicillamine in fasted and nonfasted dogs; J. Vet. Intern. Med. 27(5): 1071-6

Study Design: Dogs received D-penicillamine (12.5 mg/kg PO) fasted and with food in a randomized, crossover design to test the effect if food on the … » Mehr

HEYL

Chemisch-pharmazeutische Fabrik GmbH & Co. KG

Pharma

Mendoza FA et al. 2016; Severe eosinophilic fasciitis: Comparison of treatment with D-penicillamine plus corticosteroids versus corticosteroids alone; Scand. J. Rheumatol. 45(2):129-34

Brancaleone V et al. 2016; D-penicillamine modulates hydrogen sulfide (H₂S) pathway through selective inhibition of cystathionine-gamma-lyase (CSE); Br. J. Pharmacol. 173(9):1556-65

Karakulak UN et al. 2015; An arrhythmic episode after mercury exposure and successful treatment with chelation therapy: A case report; Anatol. J. Cardiol. 15:586-91

Gaidukov SN et al. 2013; Features of the early neonatal period at children born from mothers with the critical values of mercury in their blood; Mod. Problems Sci. Educat. No. 6

Mirzoev EB et al. 2015; The influence of hexacyanoferrate (II) potassium-ferric(III) as a radionuclide sorbent fed at different doses on clinical, hematological and physiological parameters in rats; Agric. Biol. 50(2):237-44

Parajuli D et al. 2013; Prussian blue nanoparticles for the enrichment of radioactive cesium in colutions; Waste Management Conference: International collaboration and continuous improvement, Phoenix, AZ (USA), 24-28 Feb 2013

Langlois DK et al. 2013; Pharmacokinetics and relative bioavailability of D-penicillamine in fasted and nonfasted dogs; J. Vet. Intern. Med. 27(5): 1071-6